CD34 (+) cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory angina

Patients with refractory angina who are suboptimal candidates for further revascularization have improved exercise time, decreased angina frequency, and reduced major adverse cardiac events with intramyocardial delivery of CD34(+) cells. However, the effect of CD34(+) cell therapy on health care exp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stem Cells Transl Med
Main Authors: Johnson, Grace L., Henry, Timothy D., Povsic, Thomas J., Losordo, Douglas W., Garberich, Ross F., Stanberry, Larissa I., Strauss, Craig E., Traverse, Jay H.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2020
Assuntos:
Human Clinical Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7519768/
https://ncbi.nlm.nih.gov/pubmed/32531108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.20-0046
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados